Publicaciones en colaboración con investigadores/as de Instituto de Salud Global de Barcelona (15)

2023

  1. Corrigendum: CARB-ES-19 multicenter study of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli from all Spanish provinces reveals interregional spread of high-risk clones such as ST307/OXA-48 and ST512/KPC-3(Front. Microbiol., (2022), 13, (918362), 10.3389/fmicb.2022.918362)

    Frontiers in Microbiology

  2. The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)

    Frontiers in Microbiology, Vol. 14

2022

  1. CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3

    Frontiers in Microbiology, Vol. 13

  2. Hidden dissemination of carbapenem-susceptible OXA-48-producing Proteus mirabilis

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 11, pp. 3009-3015

2021

  1. Uptake of ozenoxacin and other quinolones in gram-positive bacteria

    International Journal of Molecular Sciences, Vol. 22, Núm. 24

2020

  1. Comparative activity of ozenoxacin and other quinolones in Staphylococcus aureus strains overexpressing the efflux pump-encoding genes mepA and norA

    International Journal of Antimicrobial Agents, Vol. 56, Núm. 3

2019

  1. Microbiological profile of ozenoxacin

    Future Microbiology, Vol. 14, Núm. 9, pp. 773-787

  2. Mutant prevention concentration of ozenoxacin for quinolone-susceptible or - resistant Staphylococcus aureus and Staphylococcus epidermidis

    PLoS ONE, Vol. 14, Núm. 10

2018

  1. Comparative in vitro antibacterial activity of ozenoxacin against Gram-positive clinical isolates

    Future Microbiology, Vol. 13, Núm. 6s, pp. 3-19

2016

  1. Escherichia coli: An old friend with new tidings

    FEMS Microbiology Reviews, Vol. 40, Núm. 4, pp. 437-463

2015

  1. Evaluation of the eazyplex® SuperBug CRE system for rapid detection of carbapenemases and ESBLs in clinical Enterobacteriaceae isolates recovered at two Spanish hospitals

    Journal of Antimicrobial Chemotherapy, Vol. 70, Núm. 4, pp. 1047-1050

  2. In vitro selection of mutants resistant to ozenoxacin compared with levofloxacin and ciprofloxacin in Gram-positive cocci

    Journal of Antimicrobial Chemotherapy, Vol. 70, Núm. 1, pp. 57-61

2014

  1. Characterization of variables that may influence ozenoxacin in susceptibility testing, including MIC and MBC values

    Diagnostic Microbiology and Infectious Disease, Vol. 78, Núm. 3, pp. 263-267

2013

  1. In vitro activity of ozenoxacin against quinolone-susceptible and quinolone-resistant gram-positive bacteria

    Antimicrobial Agents and Chemotherapy, Vol. 57, Núm. 12, pp. 6389-6392

  2. Risk factors and effectiveness of preventive measures against influenza in the community

    Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183